XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 6,284 $ 6,896
Short-term investments 367 383
Trade receivables, less allowances of $439 in 2024 and $444 in 2023 6,605 6,565
Inventories:    
Finished products 4,063 3,946
Work in process 881 807
Materials 1,883 1,817
Total inventories 6,827 6,570
Prepaid expenses and other receivables 2,293 2,256
Total Current Assets 22,376 22,670
Investments 818 799
Property and equipment, at cost 22,055 21,933
Less: accumulated depreciation and amortization 11,948 11,779
Net property and equipment 10,107 10,154
Intangible assets, net of amortization 8,296 8,815
Goodwill 23,383 23,679
Deferred income taxes and other assets 7,487 7,097
Total Assets 72,467 73,214
Current Liabilities:    
Trade accounts payable 4,178 4,295
Salaries, wages and commissions 1,092 1,597
Other accrued liabilities 5,220 5,422
Dividends payable 959 955
Income taxes payable 562 492
Current portion of long-term debt 2,010 1,080
Total Current Liabilities 14,021 13,841
Long-term debt 12,576 13,599
Post-employment obligations, deferred income taxes and other long-term liabilities 6,827 6,947
Commitments and Contingencies
Shareholders’ Investment:    
Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued 0 0
Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2024: 1,989,789,999; 2023: 1,987,883,852 24,726 24,869
Common shares held in treasury, at cost — Shares: 2024: 250,155,515; 2023: 253,807,494 (15,761) (15,981)
Earnings employed in the business 38,011 37,554
Accumulated other comprehensive income (loss) (8,166) (7,839)
Total Abbott Shareholders’ Investment 38,810 38,603
Noncontrolling Interests in Subsidiaries 233 224
Total Shareholders’ Investment 39,043 38,827
Total Liabilities and Shareholders' Investment $ 72,467 $ 73,214